Eligibility criteria for clinical trials report challenges in representing LN patients
High magnification micrograph of diffuse proliferative lupus nephritis. Credit: Nephron.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
